BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1789272)

  • 1. Increase in 2',5'-oligoadenylate synthetase caused by deoxycoformycin in hairy cell leukaemia.
    Ganeshaguru K; de Mel WC; Sissolak G; Catovsky D; Dearden CE; Mehta AB; Hoffbrand AV
    Adv Exp Med Biol; 1991; 309A():65-8. PubMed ID: 1789272
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of intracellular and plasma 2',5'-oligoadenylate synthetase by pentostatin.
    Ho AD; Klotzbücher A; Gross A; Dietz G; Mestan J; Jakobsen H; Hunstein W
    Leukemia; 1992 Mar; 6(3):209-14. PubMed ID: 1564958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in 2',5'-oligoadenylate synthetase caused by deoxycoformycin in hairy cell leukaemia.
    Ganeshaguru K; de Mel WC; Sissolak G; Catovsky D; Dearden CE; Mehta AB; Hoffbrand AV
    Br J Haematol; 1992 Feb; 80(2):194-8. PubMed ID: 1550776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined effects of interferon and 2'-deoxycoformycin on 2',5'-oligoadenylate synthetase and adenosine deaminase in hairy cell and chronic lymphocytic leukemia cells.
    Triozzi PL; Avery KA; Grever MR; Kraut EH
    J Interferon Res; 1990 Oct; 10(5):535-40. PubMed ID: 2273300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological recovery and dose evaluation in IFN-alpha treatment of hairy cell leukemia: analysis of leukocyte differentiation antigens, NK and 2',5'-oligoadenylate synthetase activity.
    Nielsen B; Hokland M; Justesen J; Hasselbalch H; Ellegaard J; Hokland P
    Eur J Haematol; 1989 Jan; 42(1):50-9. PubMed ID: 2914594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hairy cell leukemia successfully treated with 2'-deoxycoformycin following refractoriness to splenectomy and alpha-interferon therapy].
    Shibata T; Hotta T
    Rinsho Ketsueki; 1992 Feb; 33(2):216-20. PubMed ID: 1635172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
    Gotić M; Rolović Z; Radosević N; Draguljac N; Jovanović V; Bogdanović A; Bosković D
    Srp Arh Celok Lek; 2000; 128(7-8):262-70. PubMed ID: 11089434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of hair cell leukemia with 2'-deoxycoformycin after failure of interferons alpha or beta.
    Dutcher JP; Salva KM; Wiernik PH
    Am J Clin Oncol; 1990 Aug; 13(4):290-3. PubMed ID: 2198792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential administration of recombinant interferon alpha and deoxycoformycin in the treatment of hairy cell leukaemia.
    Habermann TM; Andersen JW; Cassileth PA; Bennett JM; Oken MM
    Br J Haematol; 1992 Apr; 80(4):466-71. PubMed ID: 1581231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do we know the treatment of choice for hairy cell leukemia?
    Golomb HM
    Ann Oncol; 1994 Oct; 5(8):676-7. PubMed ID: 7826898
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic advances in the treatment of hairy cell leukemia.
    Andrey J; Saven A
    Leuk Res; 2001 May; 25(5):361-8. PubMed ID: 11301103
    [No Abstract]   [Full Text] [Related]  

  • 12. [Alpha interferon treatment in hairy cell leukemia].
    Hagberg H
    Nord Med; 1992; 107(3):74-5. PubMed ID: 1347920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of 2',5 oligoadenylate synthetase during interferon therapy in patients with B-cell chronic lymphocytic leukemia.
    Musolino C; Grosso P; Alonci A; Allegra A; Orlando A; Cincotta M; Buda G; Squadrito G
    Am J Hematol; 1993 May; 43(1):1-4. PubMed ID: 8317456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hairy cell leukemia and its treatment with 2-chlorodeoxyadenosine (2-CdA)].
    Pawelski S
    Acta Haematol Pol; 1995; 26(2):139-43. PubMed ID: 7653218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo and in vitro induction of (2'-5') oligoadenylate synthetase by human interferons in leukocytes from healthy donors and patients with renal cancer and hairy cell leukemia.
    Ferbus D; Billard C; Sigaux F; Thang MN; Falcoff E
    J Biol Regul Homeost Agents; 1987; 1(3):147-53. PubMed ID: 2459906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: an intergroup study.
    Grever M; Kopecky K; Foucar MK; Head D; Bennett JM; Hutchison RE; Corbett WE; Cassileth PA; Habermann T; Golomb H
    J Clin Oncol; 1995 Apr; 13(4):974-82. PubMed ID: 7707126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of aplastic variant of hairy-cell leukaemia with deoxycoformycin.
    Ng JP; Nolan B; Chan-Lam D; Coup AJ; McKenna D
    Hematology; 2002 Aug; 7(4):259-62. PubMed ID: 14972788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hairy cell leukemia: treatment successes in the past 25 years.
    Golomb HM
    J Clin Oncol; 2008 Jun; 26(16):2607-9. PubMed ID: 18509168
    [No Abstract]   [Full Text] [Related]  

  • 19. Hairy cell leukaemia: review of treatment.
    Kurzrock R; Talpaz M; Gutterman JU
    Br J Haematol; 1991 Oct; 79 Suppl 1():17-20. PubMed ID: 1718389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal treatment for untreated patients with hairy cell leukemia?
    Troussard X; Flandrin G
    J Clin Oncol; 1995 Oct; 13(10):2677-9. PubMed ID: 7595722
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.